# Hour 07: 07:00-07:59 - Daytime Operations Begin

Released on 1 May 2026 | CEO Kevin Kawchak | ChemicalQDevice

## Hour Summary

Daytime ramp accelerates. 6 new arrivals across the network. First adverse
event of the cycle: PAT-CONT-0007 (post-IND C1D1) reports grade 1 fatigue.

## Cross-Site Status at 07:00 UTC

| Site | Patients | Active | Standby | Active | Signal |
|------|----------|--------|---------|--------|--------|
| SITE-A | 9 | 1 | 28 | 1 | UP |
| SITE-B | 7 | 0 | 29 | 0 | UP |
| SITE-C | 5 | 0 | 29 | 0 | UP |
| SITE-D | 5 | 0 | 29 | 0 | UP |

## New Arrivals

| Patient ID | Site | Time | Cancer | Robot |
|------------|------|------|--------|-------|
| PAT-CONT-0018A | SITE-B | 07:04 | Brain (GBM) | RT Pos (3) |
| PAT-CONT-0019A | SITE-A | 07:11 | Liver HCC ablation | Steerable Needle (9) |
| PAT-CONT-0020A | SITE-C | 07:24 | LS-SCLC restage | Imaging (8) |
| PAT-CONT-0021A | SITE-A | 07:35 | Pediatric osteosarcoma rehab | Rehab (10) |
| PAT-CONT-0022A | SITE-D | 07:42 | Pediatric ALL maintenance | Companion (5) |
| PAT-CONT-0023A | SITE-B | 07:55 | Sarcoma biopsy | Cobot (2) |

## Minute Activity Log

```
07:00 Hour-boundary FDA recon: 4/4 endpoints accepted from hour 06.
07:00-07:08 PAT-CONT-0017A RT delivery completes (TRACK-01 SITE-A).
07:09 RT endpoint streamed: TRAVERSE-CONT-0017A-RT22. FDA ack 07:09+10s.
07:04 PAT-CONT-0018A check-in SITE-B. RT vault 1 prep.
07:11 PAT-CONT-0019A check-in SITE-A. Liver ablation suite prep.
07:13-07:25 STEER-02 (SITE-A) ablation prep + needle 1 placement.
07:14 RTPOS-02 (SITE-B) wakes. Patient positioned 07:18.
07:19-07:38 Brain RT delivery (4 fields, 2 Gy).
07:24 PAT-CONT-0020A check-in SITE-C. CT restaging.
07:25-07:42 IMAGE-04 (SITE-C) thoracic CT + lesion measurement.
07:26-07:55 STEER-02 microwave ablation cycle.
07:35 PAT-CONT-0021A check-in SITE-A. Rehab session.
07:36-07:54 REHAB-02 (SITE-A) gait + strength session.
07:39 BR endpoint streamed: TRAVERSE-CONT-0018A-RT08. FDA ack 07:39+11s.
07:42 PAT-CONT-0022A check-in SITE-D. Pediatric maintenance.
07:43-07:58 COMPN-04 engagement + oral 6-MP.
07:43 IMG endpoint streamed: STREAM-CONT-0020A-RESTAGE. FDA ack 07:43+12s.
07:48 AE flag: PAT-CONT-0007 (SITE-B, post-IND obs) reports grade 1 fatigue.
      SSO notified. Vitals reassessed: BP 132/78, HR 84, SpO2 97%. AE log
      entry created. RTCT priority signal: TRAVERSE-CONT-0007-AE-FATIGUE-G1.
07:48 AE endpoint streamed at high priority. FDA ack 07:48+8s (priority).
07:55 PAT-CONT-0023A check-in SITE-B. Sarcoma biopsy.
07:55 SD endpoint streamed: TRAVERSE-CONT-0019A-ABL01-COMPLETE. FDA ack 12 s.
07:56 COBOT-03 (SITE-B) wakes for biopsy.
07:57-07:59 Pre-procedure matrix; biopsy continues hour 08.
```

## Departures
None.

## Adverse Events
- **AE-001**: PAT-CONT-0007 (SITE-B), grade 1 fatigue, post-IND C1D1.
  CTCAE v5.0 grade 1, expected per IB. Logged at 07:48.

## IND Administrations
PAT-CONT-0022A: pediatric maintenance dose, supervised.

## Cross-Site Utilization
- SITE-A: 78 robot-min (TRACK-01 wrap, STEER-02, REHAB-02)
- SITE-B: 42 robot-min (RTPOS-02 + IMAGE-04 brain RT) + COBOT-03 prep
- SITE-C: 17 robot-min (IMAGE-04)
- SITE-D: 16 robot-min (COMPN-04)
- Network utilization: 2.20%

## RTCT Signal Stream

| Signal ID | Patient | Endpoint | FDA Ack |
|-----------|---------|----------|---------|
| TRAVERSE-CONT-0017A-RT22 | PAT-CONT-0017A | RT22 done | 10 s |
| TRAVERSE-CONT-0018A-RT08 | PAT-CONT-0018A | GBM RT8 done | 11 s |
| STREAM-CONT-0020A-RESTAGE | PAT-CONT-0020A | Restage CT | 12 s |
| TRAVERSE-CONT-0019A-ABL01-COMPLETE | PAT-CONT-0019A | Ablation done | 12 s |
| TRAVERSE-CONT-0007-AE-FATIGUE-G1 | PAT-CONT-0007 | AE grade 1 | **8 s** (priority) |
| TRAVERSE-PED-CONT-0022A-MAINT01 | PAT-CONT-0022A | Maintenance dose | (in flight) |
